// App-Quantinova.ai

e23268 : Correlation of loss of ataxia-telangiectasia-mutated protein expression with poor prognosis and benefit from anthracycline containing adjuvant chemotherapy in breast cancer.

Researchers

Presenter

  • Koung Jin Suh

Principal Investigators

  • Han Suk Ryu

  • Kyung-Hun Lee

  • Hyojin Kim

  • Ahrum Min

  • Tae-Yong Kim

  • Yaewon Yang

  • Hyeong-Gon Moon

  • Sae-Won Han

  • Do-Youn Oh

  • Wonshik Han

  • In Ae Park

  • Dong-Young Noh

  • Seock-Ah Im

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Ataxia telangiectasia

  • Breast cancer

  • Seizures sensorineural deafness ataxia mental retardation electrolyte imbalance

  • Solid malignancies

Biomarkers

  • Ataxia-telangiectasia mutated

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved